First Header Logo Second Header Logo

Connection

Elizabeth Alli to Drug Synergism

Back to Details
This is a "connection" page, showing publications Elizabeth Alli has written about Drug Synergism.
Elizabeth Alli
Connection Strength
0.023
Drug Synergism
  1. Hastak K, Alli E, Ford JM. Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. Cancer Res. 2010 Oct 15; 70(20):7970-80.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.